Clinical Trial Update: Effect of High- and Low-sodium Intake on the Pharmacokinetics and Pharmacodynamic Effects of Fimasartan [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how high versus low sodium intake affects the pharmacokinetics and pharmacodynamics of fimasartan in hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Fimasartan (fimasartan)

Snippet

Sponsor: DongGuk University | Conditions: Hypertension | Phase 4 | Status: COMPLETED